Viewing Study NCT00933205


Ignite Creation Date: 2025-12-25 @ 3:33 AM
Ignite Modification Date: 2025-12-26 @ 2:15 AM
Study NCT ID: NCT00933205
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2016-11-30
First Post: 2009-07-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module